Showing results (1-10 of 258) with videos related to
Sort By:
Pageof 26
PET Clinics|November 19, 2019
Current Evidence on PET Response Assessment to Immunotherapy in LymphomasEgesta Lopci, Michel MeignanSeminars in Nuclear Medicine|February 11, 2025
Current Status of Staging and Restaging Malignant Pleural MesotheliomaEgesta LopciJournal of Clinical Medicine|November 13, 2021
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [18F]FDG PET/CT in Metastatic Melanomas and Lung CancerEgesta LopciJournal of Clinical Medicine|June 10, 2022
Meditating on Cancer Management at the Time of ImmunotherapyEgesta LopciThe Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2019
Response assessment of bone metastatic disease: seeing the forest for the trees RECIST, PERCIST, iRECIST, and PCWG-2Angelo Castello, Egesta LopciRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 27, 2012
Molecular imaging in oncologyEgesta Lopci, Stefano FantiRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 29, 2020
Non-FDG PET/CTEgesta Lopci, Stefano FantiThe Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 29, 2020
Update on tumor metabolism and patterns of response to immunotherapyAngelo Castello, Egesta LopciCurrent Radiopharmaceuticals|November 22, 2019
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of ArtAngelo Castello, Egesta LopciPageof 26